MedTrace Logo

Double-blind Randomized Clinical Trial of Transcranial Magnetic Stimulation in Chronic Migraine

NCT01496950 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2018-04-05

No results posted yet for this study

Summary

The purpose of this study is to determine whether active repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex is safe and effective for preventive treatment of chronic migraine, compared to placebo repetitive transcranial magnetic stimulation.

Conditions

  • Chronic Migraine

Interventions

DEVICE

10Hz active rTMS

10Hz active rTMS delivered to the left dorsolateral prefrontal cortex

DEVICE

Placebo

10Hz placebo rTMS delivered to the vertex

Sponsors & Collaborators

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

    collaborator OTHER_GOV

  • Hospital Israelita Albert Einstein

    lead OTHER

Principal Investigators

  • Adriana Conforto, MD,PHD · Instituto Israelita de Ensino e Pesquisa Albert Einstein

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-10-31
Primary Completion
2011-12-31
Completion
2012-02-29

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01496950 on ClinicalTrials.gov